Research

Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/29244234/

Learn more
Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/28628235/

Learn more
DPPX antibody-associated encephalitis: Main syndrome and antibody effects February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379928/

Learn more
Anti-DPPX encephalitis. Pathogenic effects of antibodies on gut and brain neurons February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560062/

Learn more
DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240433/

Learn more
Oro-Bucco-Lingual Dyskinesia, Weight Loss, and Cognitive Decline in Anti-DPPX Antibody-Mediated Encephalitis February 27, 2021

https://onlinelibrary.wiley.com/doi/10.1002/mdc3.13058

Learn more
Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824142/

Learn more
Clinical Characteristics of Anti-GABA-B Receptor Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253677/

Learn more
Encephalitis With Antibodies Against the GABAB Receptor: High Mortality and Risk Factors February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798040/

Learn more
A systematic review of Gamma-aminobutyric Acid Receptor Type B autoimmunity February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/30620044/

Learn more